Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis
Evan S. Dellon(University of North Carolina at Chapel Hill), Vincent A. Mukkada(Cincinnati Children's Hospital Medical Center), Yehudith Assouline-Dayan(University of Iowa Hospitals and Clinics), Neal S. LeLeiko, Ikuo Hirano(Northwestern University), John M. Wo, Thirumazhisai S. Gunasekaran, Amir F. Kagalwalla, Kathryn A. Peterson(University of Utah), Keith Friedenberg, Mohamed Hamdani(Balance Therapeutics (United States)), Rebecca N. Cherry, John Leung(Tufts University), Gary W. Falk, Margaret H. Collins, David A. Katzka(Columbia University Irving Medical Center), Sandeep K. Gupta, Michael H. Hart, Brad Pasternak, Jeffrey D. Lewis, Michael F. Vaezi(Vanderbilt University Medical Center), Mark Ellis, Samuel Nurko(Boston Children's Hospital), Jonathan E. Markowitz, Laurel L. Prestridge
Cited by 228
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
|The American Journal of Gastroenterology|2015|1.5k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k